Loading...
Market
What will be the outcome of the Senate vote on the Biosecure Act by February 28, 2025?
2
Resolution / Starting Odds
Passed with amendments • 25%
Passed without amendments • 25%
Rejected • 25%
Postponed • 25%
Official Senate voting record
Story
Congress Weighs Biosecure Act to Restrict Blacklisted Chinese Biotech Firms Over DNA Collection
Dec 5, 2024, 03:39 PM
The U.S. Congress is considering the Biosecure Act, a legislative measure aimed at restricting blacklisted Chinese biotechnology firms linked to the Chinese military from operating in the United States. These companies are allegedly collecting DNA data from American citizens and using it for military experiments, including the development of bio-weapons and complex viruses. The bill has passed the House of Representatives and now awaits Senate approval. Supporters of the bill argue that it is essential for safeguarding national security, economic independence, and preventing potential threats posed by Chinese military-linked entities. Lawmakers are reportedly exploring a potential compromise to advance the legislation.
View original story
Similar markets
Passed • 33%
Failed • 33%
Not Voted • 33%
Passes • 33%
Fails • 33%
Postponed • 34%
Passed without amendments • 25%
Passed with amendments • 25%
Rejected • 25%
No vote by deadline • 25%
Passed with majority Republican support • 25%
Passed with bipartisan support • 25%
Failed with majority Democrat opposition • 25%
Failed with bipartisan opposition • 25%
Pass with majority support • 25%
Fail with majority opposition • 25%
Tied vote • 25%
Not brought to vote • 25%
Passes with 51-59 votes • 25%
Passes with 60 or more votes • 25%
Fails with 50 or fewer votes • 25%
Not voted on by December 31, 2024 • 25%
Pass with majority Republican support • 25%
Pass with bipartisan support • 25%
Fail with majority Democratic opposition • 25%
Fail with bipartisan opposition • 25%
Pass with > 60% support • 25%
Pass with 50-60% support • 25%
Fail with < 50% support • 25%
No vote by December 31, 2024 • 25%
Pass with unanimous vote • 25%
Pass with majority vote • 25%
Fail to pass • 25%
Not voted on by deadline • 25%
Passes with majority • 33%
Fails to pass • 33%
Not voted on by deadline • 34%
Pass • 33%
Fail • 33%
Postponed • 33%
Passes with majority Republican support • 25%
Passes with bipartisan support • 25%
Fails with majority Democrat opposition • 25%
Fails with bipartisan opposition • 25%